Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rauch

Showing results (51-60 of 307) with videos related to

Pageof 31
Sort By:
Bone|April 3, 2021
Muscle transcriptome in mouse models of osteogenesis imperfectaPierre Moffatt, Iris Boraschi-Diaz, Ghalib Bardai, et al.
Journal of Osteoporosis|September 14, 2011
Genotype-phenotype correlations in autosomal dominant osteogenesis imperfectaI Mouna Ben Amor, Francis H Glorieux, Frank Rauch
The Journal of Clinical Endocrinology and Metabolism|January 26, 2006
Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuationFrank Rauch, Craig Munns, Christof Land, et al.
Bone|November 28, 2006
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatmentChristof Land, Frank Rauch, Rose Travers, et al.
Health and Quality of Life Outcomes|February 5, 2015
Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfectaMaman Joyce Dogba, Frank Rauch, Erin Douglas, et al.
Pediatric Nephrology (Berlin, Germany)|August 9, 2019
Mineralized tissues in hypophosphatemic ricketsMarie-Eve Robinson, Haitham AlQuorain, Monzur Murshed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 4, 2003
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapyFrank Rauch, Horacio Plotkin, Leonid Zeitlin, et al.
The Journal of Clinical Investigation|November 6, 2002
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfectaFrank Rauch, Rose Travers, Horacio Plotkin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2004
Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysisFrank Rauch, Rose Travers, Craig Munns, et al.
The Journal of Pediatrics|November 24, 2015
Body Composition in Children and Adolescents with Osteogenesis ImperfectaTelma Palomo, Francis H Glorieux, Eckhard Schoenau, et al.
Pageof 31

Showing results (51-60 of 307) with videos related to

Sort By:
Pageof 31
Bone|April 3, 2021
Muscle transcriptome in mouse models of osteogenesis imperfectaPierre Moffatt, Iris Boraschi-Diaz, Ghalib Bardai, et al.
Journal of Osteoporosis|September 14, 2011
Genotype-phenotype correlations in autosomal dominant osteogenesis imperfectaI Mouna Ben Amor, Francis H Glorieux, Frank Rauch
The Journal of Clinical Endocrinology and Metabolism|January 26, 2006
Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuationFrank Rauch, Craig Munns, Christof Land, et al.
Bone|November 28, 2006
Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatmentChristof Land, Frank Rauch, Rose Travers, et al.
Health and Quality of Life Outcomes|February 5, 2015
Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfectaMaman Joyce Dogba, Frank Rauch, Erin Douglas, et al.
Pediatric Nephrology (Berlin, Germany)|August 9, 2019
Mineralized tissues in hypophosphatemic ricketsMarie-Eve Robinson, Haitham AlQuorain, Monzur Murshed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 4, 2003
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapyFrank Rauch, Horacio Plotkin, Leonid Zeitlin, et al.
The Journal of Clinical Investigation|November 6, 2002
The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfectaFrank Rauch, Rose Travers, Horacio Plotkin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2004
Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysisFrank Rauch, Rose Travers, Craig Munns, et al.
The Journal of Pediatrics|November 24, 2015
Body Composition in Children and Adolescents with Osteogenesis ImperfectaTelma Palomo, Francis H Glorieux, Eckhard Schoenau, et al.
Pageof 31